Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety
Alexandra Thoenes, Luca Cariolato, Julian Spierings et al. · Drugs - Real World Outcomes · 2020
Abstract onlyNot checked
Medicine: papers
Filters1 filter applied
Status
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
Evaluation of the attitudes of specialist and family physicians regarding rational drug selection
Ahmet Akici, Volkan Aydin, Salih Mollahaliloglu et al. · İstanbul Kuzey Klinikleri · 2018
Abstract onlyNot checked
Telegraph communication networks used by the Japanese pharmaceutical industry in 1901
Amijima Takashi · Miscellanea Geographica: Regional Studies on Development · 2019
Abstract onlyNot checked
Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study
Afsana Afroz, Khurshid Alam, Liaquat Ali et al. · BMC Health Services Research · 2019
Abstract onlyNot checked
Social capital, faith-based organizations, and Malawi persons living with HIV (PLWH)
S. Jong, S. Rankin · Annals of Global Health · 2014
Abstract onlyNot checked
Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte et al. · Biomedicine Hub · 2020
Abstract onlyNot checked
Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches
Elena Nicod, Amanda Whittal, Michael Drummond et al. · Orphanet Journal of Rare Diseases · 2020
Abstract onlyNot checked
Access to Oncology Drugs in Brazil: Juggling Innovation and Sustainability in Developing Countries
Felipe Ades · Medicine Access @ Point of Care · 2017
Abstract onlyNot checked
The US Affordable Care Act: Reflections and directions at the close of a decade.
Adrianna McIntyre, Zirui Song · PLoS Medicine · 2019
Abstract onlyNot checked
Access to In-Network Emergency Physicians and Emergency Departments Within Federally Qualified Health Plans in 2015
Stephen C. Dorner, MSc, Carlos A. Camargo, Jr., MD, DrPH, Jeremiah D. Schuur, MD, MHS et al. · Western Journal of Emergency Medicine · 2016
Abstract onlyNot checked
Early Poverty and Future Life Expectancy with Disability among the Elderly in Argentina
Malena Monteverde, Alberto Palloni, Montserrat Guillén et al. · Revista Latinoamericana de Población · 2019
Abstract onlyNot checked
The effect of a change in co-payment on prescription drug demand in a National Health System: The case of 15 drug families by price elasticity of demand.
Cristina Hernández-Izquierdo, Beatriz González López-Valcárcel, Stephen Morris et al. · PLoS ONE · 2019
Abstract onlyNot checked
Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia
Astrid J. Rodriguez-Acevedo, Raymond J. Chan, Catherine M. Olsen et al. · BMC Cancer · 2021
Abstract onlyNot checked
Trends in and drivers of healthcare expenditure in the English NHS: a retrospective analysis
Idaira Rodriguez Santana, María José Aragón, Nigel Rice et al. · Health Economics Review · 2020
Abstract onlyNot checked
Review of Claire Laurier Decoteau, Ancestors and Antiretrovirals: The Biopolitics of HIV/AIDS in Post-Apartheid South Africa
Lauren Paremoer · Journal of World-Systems Research · 2015
Abstract onlyNot checked
Creative Destruction: Next Generation Sequencing in Drug Development, Formulary Evaluations and Pricing
Paul C Langley · INNOVATIONS in Pharmacy · 2016
Abstract onlyNot checked
Hepatitis C drug affordability
Mohga Kamal-Yanni · The Lancet Global Health · 2015
Abstract onlyNot checked
Drug Repurposing for Rare Diseases: A Role for Academia
Sibren van den Berg, Sibren van den Berg, Saco de Visser et al. · Frontiers in Pharmacology · 2021
Abstract onlyNot checked
Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis
Nicolas Iragorri, Eldon Spackman · Public Health Reviews · 2018
Abstract onlyNot checked
Invited Speaker Text
Mark Nuijten · Biotechnology & Biotechnological Equipment · 2021
Abstract onlyNot checked